Clinical Research News
-
Merck, Pfizer give information of Avelumab in Refractory Ovarian Cancer
Clinical Research | News | 0 Comment | 20 Nov, 2018
Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy,...Read more
-
Vyera to Initiate Phase 1 Study of NCE for Toxoplasmosis
Clinical Research | News | 0 Comment | 16 Nov, 2018
Vyera Pharmaceuticals, LLC has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of VYR-006, a novel dihydrofolate reductase (DHFR) inhibitor which Vyera...Read more
-
Nashville Biosciences enters into agreement with BC Platforms
Clinical Research | News | 0 Comment | 15 Nov, 2018
Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt Uni...Read more
-
3-D study delivers first pre-clinical results on the toxicological impact of novel e-cigarette
Clinical Research | News | By Keyur Trivedi, M.Phil., M.Sc., Philip Morris International | 0 Comment | 12 Nov, 2018
Singapore - Philip Morris International (PMI), has conducted an in vitro study using epithelial cells taken from the mouth and small airways of a human donor, in early stage, pre-clinical a...Read more
-
Adagene announces acceptance of IND in China for ADG-106
Clinical Research | News | 0 Comment | 01 Nov, 2018
Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, California has announced the dosing of its first patient in its Phase I tr...Read more
-
Daiichi enters clinical collaboration with Merck, Pfizer
Clinical Research | News | 0 Comment | 27 Oct, 2018
Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer, Inc. to evaluate the combination ...Read more
-
Eisai announces Data from the Phase II Clinical Trial of BAN2401
Clinical Research | News | 0 Comment | 26 Oct, 2018
Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented the latest data from the Phase II clinical study (Study 201) of BAN2401, an anti-amyloid beta protofibril antibody, in 856 pat...Read more
-
Reistone Biopharma to intiate Ph 2 clinical trial of Ulcerative Colitis globally
Clinical Research | News | 0 Comment | 23 Oct, 2018
Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced the US FDA approval of IND for phase II clinical trial to invest...Read more
-
ASLAN reveals promising data for advanced solid tumour drug
Clinical Research | News | 0 Comment | 22 Oct, 2018
Singapore – ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States...Read more
-
apceth Biopharma announces positive results for apceth-201 in mouse models
Clinical Research | News | 0 Comment | 19 Oct, 2018
apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies has announced positive results for apceth-201 in mouse models for ac...Read more
-
Medivir lowers research costs to focus on clinical development
Clinical Research | News | 0 Comment | 17 Oct, 2018
Singapore - Medivir AB announced plans to reduce activities not critical to its development pipeline of drug candidates as part of its enhanced focus on clinical stage projects. As part of...Read more
-
Alphamab starts phase I clinical trial in Australia
Clinical Research | News | 0 Comment | 11 Oct, 2018
Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of its class, has recently started phase I clinical trial in Australia. ...Read more
-
Yisheng receives approval for rabies vaccine clinical study
Clinical Research | News | 0 Comment | 10 Oct, 2018
Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immune modulator biotherapeutics and vaccines, has announce...Read more
-
Eisai receives FDA approval for antiepileptic drug
Clinical Research | News | 0 Comment | 01 Oct, 2018
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic dr...Read more
-
Atox Bio announces completion of pre-planned safety review
Clinical Research | News | 0 Comment | 25 Sep, 2018
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced that the independent Data Monitoring Committee (DMC) has completed its ...Read more
-
Immutep collaborates with Merck, Pfizer for Efti
Clinical Research | News | 0 Comment | 25 Sep, 2018
Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination o...Read more
-
Proxima Clinical Research appoints David Novotny as CSO
Clinical Research | News | 0 Comment | 24 Sep, 2018
David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinical trial and strategic services. Mr. Novotny will be a member of the e...Read more
-
Clinical Research | Opinion | By Priyanka Bajpai | 0 Comment | 20 Sep, 2018
Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challenges that we see in clinical laboratories practices? The rapidly evolv...Read more
